Coya Therapeutics closes $13M IPO to advance clinical trials
January 05, 2023 at 15:04 PM EST
Coya Therapeutics, which is working toward FDA approval of its drugs targeting neurodegenerative diseases, will use its IPO funds to further develop its preclinical trials
